N7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines Represent a Versatile Class of Potent Inhibitors of the Tyrosine Kinase c-Src
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
201-208
Author(s):
Eva Altmann, Leo Widler and Martin Missbach
Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
261-269
Author(s):
V. C.O. Njar
The Antiprogestogen Mifepristone: A Review
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
71-90
Author(s):
Premila W. Ashok, Prabath T. Wagaarachchi and Allan Templeton
Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
Journal:
Current Gene Therapy
Volume:
2
Page:
227-234
Author(s):
Thomas Licht and Chrisitian Peschel
Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
387-401
Author(s):
M. Tolomeo and D. Simoni
Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper